The quenching of tryptophan fluorescence has been used to determine the kinetic and thermodynamic parameters of binding of B-ring analogs of colchicine to tubulin. The on rate, activation energy, off-rate, and thermodynamics of binding reaction have been found to be controlled at different points of analog structure. The on-rate and off-rate of deacetamidocolchicine (DAAC) binding with tubulin is 17 times slower than that of 2-methoxy-5-(2,3,4-trimethoxyphenyl)tropone-tubulin (AC-tubulin) interaction, although both reactions have very similar activation energies. The presence of B-ring alone does not significantly affect the thermodynamics of the binding reactions either, since both AC-tubulin and DAAC-tubulin interactions are enthalpy driven. Introduction of a NH 2 group at C-7 position of the B-ring, as in deacetylcolchicine (NH 2 -DAAC) lowers the on-rate further with a significant rise in the value of the activation energy. However, bulkier substitutions at the same position, as in demecolcine (NHMe-DAAC) and N-methyldemecolcine (NMe 2 -DAAC) have no significant additional effect either on the on-rate or on the value of activation energy. Introduction of NH 2 group in the C-7 position of B-ring also increases the positive entropy of the binding reaction to a significant extent, and it is maximum when NMe 2 is substituted instead of NH 2 group. Thus, interaction of NH 2 -DAAC, NHMe-DAAC, and NMe 2 -DAAC with tubulin are entropy driven. Our results suggest that the B-ring side chain of aminocolchicinoids makes contact(s) with dimeric tubulin molecules.Colchicine, the major alkaloid in Colchicum autumnale, is medically used for the treatment of gout (1) and Familial Mediterranean fever (2). Due to its immense therapeutic importance, a large number of colchicine and thiocolchicine analogs have been synthesized and tested for their biological activities (3-5). Colchicine exerts its antimitotic property upon binding to a high affinity site on the tubulin heterodimer (6 -8). It is composed of a trimethoxybenzene ring (A-ring), a methoxytropone ring (C-ring), and a seven-membered ring (B-ring), which anchors the A-and C-rings (Fig. 1). Structure activity studies indicate that the A-and C-rings of colchicine comprise the minimum structural features of the molecule necessary for its high affinity binding to tubulin. Insertion of a bulky group in the A-ring of colchicine, as in colchicoside, causes complete loss of binding, indicating that the requirement of the A-ring is stringent (4). On the other hand, several changes in the C-ring such as different substitutions at the C-10 position or a replacement of the seven-membered ring with a six-membered ring are tolerated (9 -14). Colchicine analogs modified at, or depleted of, the B-ring are known to retain potent antimitotic activity, self-assembly inhibitory activity, and the binding activity to tubulin at the colchicine site (15-17). Nevertheless, the presence of B-ring alone, or substituents at C-7 position, influences the on-rate, activation energy, off-rate, reversi...